Table 6 Prostate cancer member characteristics by stage, diagnosed 2016–2020 (N = 2,079)

n (%)^{a, b}

459 (22.1%)

815 (39.2%)

264 (12.7%)

541 (26.0%)

Age, mean (SD), years^b

62.8 (8.0)

66.2 (8.3)

65.8 (9.6)

68.1 (10.4)

Female Gender, n (%)^b

0. (0.0%)

0 (0.0%)

0 (0.0%)

0 (0.0%)

Insurance Type, n (%)^{a, b}

 Commercial

273 (59.5%)

344 (42.2%)

107 (40.5%)

214 (39.6%)

 Medicaid

11 (2.4%)

24 (2.9%)

6 (2.3%)

30 (5.6%)

 Medicare Advantage

156 (34.0%)

383 (47.0%)

127 (48.1%)

264 (48.8%)

 Multiple^c

0 (0.0%)

2 (0.3%)

1 (0.4%)

1 (0.2%)

 Unknown

19 (4.1%)

62 (7.6%)

23 (8.7%)

32 (5.9%)

Geographic Region, n (%)^{a, b}

 Midwest

137 (29.9%)

411 (50.4%)

116 (43.9%)

216 (39.9%)

 Northeast

289 (63.0%)

290 (35.6%)

101 (38.3%)

195 (36.0%)

 South

20 (4.4%)

57 (7.0%)

31 (11.7%)

61 (11.3%)

 West

7 (1.5%)

38 (4.7%)

8 (3.0%)

49 (9.0%)

 Unknown

6 (1.3%)

19 (2.3%)

8 (3.0%)

20 (3.7%)

CCI, mean (SD)^d

0.7 (1.2)

0.9 (1.4)

1.3 (1.8)

1.2 (1.8)

CCI, n (%)^{a, d}

 0

190 (66.0%)

269 (56.4%)

77 (50.3%)

148 (44.8%)

 1

54 (18.8%)

109 (22.9%)

26 (17.0%)

88 (26.7%)

 2

24 (8.3%)

49 (10.3%)

18 (11.8%)

43 (13.0%)

  ≥ 3

20 (6.9%)

50 (10.5%)

32 (20.9%)

51 (15.5%)